How carbs change what the same GH dose does: the two arms of GH, the 30-minute wait myth, insulin resistance and the panel that catches it early.
30 min read
Growth hormone does not build muscle by itself. It mobilises fuel directly, and it builds tissue only through a liver step that carbohydrate availability partly controls, so changing the carbohydrate changes what the same exposure does. This guide explains that mechanism, corrects the most repeated GH rules in the field, and lays out the monitoring that catches the metabolic cost while it is still reversible. It contains no dose figures for growth hormone or insulin, by design.
What's Inside
Written for enhanced lifters and coaches who already understand that GH is not directly anabolic and want the physiology that decides what a given exposure actually does. It assumes you are running or planning bloodwork and can read fasting insulin, IGF-1 and HbA1c against a baseline. It is not for anyone under 18, pregnant, diabetic or with active cancer, and it contains no dose figures for growth hormone or insulin, which is editorial policy, not a gap.
GH has two jobs that run on two different clocks. The direct arm is fast: GH binds receptors on fat cells, drives fat breakdown, raises free fatty acids and reduces glucose uptake in muscle within hours. The indirect arm is slow and passes through the liver, where GH signals the production of IGF-1, the arm associated with growth and repair. In controlled human work, GH added to training increased whole-body protein synthesis but not muscle protein synthesis, and did not add strength beyond training alone. The tissue GH reliably builds is connective tissue, and much of the lean mass that appears on a scan in the first weeks is fluid, not contractile muscle.
Yes, but it does a different job. The liver's IGF-1 response is nutritionally gated: during fasting or sustained restriction the liver becomes less responsive to GH, circulating GH rises while IGF-1 falls, and restoring carbohydrate lets the liver answer again. Low carbohydrate does not switch GH off, it redirects it, with fat mobilisation up and the IGF-1 arm down. That is a trade, not a failure, and it is the basis of how the guide treats cutting. Carbohydrate intake should still be set by training volume and your energy target first, not treated as a GH accessory, and the Calorie & Macro Calculator sets that target. No human trial has established a per-meal carbohydrate number that optimises IGF-1.
No. The rule does not survive the pharmacology: GH absorbed under the skin peaks over hours, and IGF-1 generation unfolds over hours to days, so a meal half an hour later is nowhere near the window that governs IGF-1. The useful idea inside the rule is that insulin blunts fat mobilisation, so meal timing is a trade-off between the two arms of GH, not a stopwatch. The PDF explains how that trade works and why the popular pre-bed carbohydrate arrangement carries a caution the original rule never mentioned.
Yes. GH induces insulin resistance through its own action regardless of carbohydrate intake: it drives fat breakdown, free fatty acids rise, and raised free fatty acids impair glucose uptake in muscle. Carbohydrate is not the cause, but it decides how quickly the problem shows up on a panel. The failure runs in stages, and the first stage, where the pancreas compensates and glucose stays normal, is invisible to fasting glucose and HbA1c. The marker that moves first is fasting insulin, so a panel without it looks reassuring for exactly the period when the problem is easiest to reverse. The guide's panel covers fasting insulin, glucose, HbA1c, HOMA-IR, IGF-1, lipids with ApoB, liver enzymes with GGT, thyroid with free T3 and home blood pressure. The Blood Test Selector builds it, the Bloodwork Analyzer reads it, the Thyroid Assessment Engine checks the thyroid pattern behind a poor IGF-1 response, and the Cardiac Risk Score tracks the cardiovascular side.
The full guide covers the two arms of GH, the corrected rules, building versus cutting decisions, the four-stage path to insulin resistance and the complete monitoring schedule in detail. Download the PDF for the complete reference.
This page and the full guide are for educational purposes only. They are not medical advice, a prescription or a recommendation to use growth hormone or insulin. Both are prescription medicines, insulin misuse can cause fatal low blood sugar, and the guide contains no dose figures for either. Do not start, stop or change any medication or compound without a qualified clinician. This content is not for anyone under 18, pregnant, diabetic or with active cancer.
Not directly in healthy adults: controlled studies show no extra muscle protein synthesis or strength beyond training alone. Much of the early lean mass gain is fluid, and GH mainly builds connective tissue and mobilises fat.
Because IGF-1 depends on the liver, and energy deficit, low protein, thyroid status, liver health and illness all lower it. Work through those factors with your physician before assuming anything else is wrong.
It is the arrangement most likely to raise fasting glucose, because it places the day's biggest glucose load in the window of lowest insulin sensitivity. The PDF explains the trade-offs of each timing option.
No. Insulin can cause fatal low blood sugar within minutes, often during sleep, and the guide treats the combination as the highest-risk practice in enhancement.
This guide is for educational purposes only and is not medical advice.
Newsletter
One email when a new guide, calculator or breakdown goes live. Nothing else.
